GP leaders across the country are advising practices to push back on private providers requesting input for weight-loss jab ...

The exception was SGLT2 inhibitors and GLP-1 receptor agonists ... may not have been eligible for certain medications due to contraindications or intolerances. Additionally, as with all ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Similar to semaglutide treatments like Ozempic and Wegovy, Zepbound activates receptors of hormones secreted from the intestine (GLP-1 and GIP ... qualify and have no contraindications ...

Like Ozempic® and Wegovy®, Rybelsus® contains semaglutide as its active ingredient, which is a glucagon-like peptide-1 receptor agonist (GLP-1RA ... or cardiovascular disease). Contraindications: ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Sharon Mann has lost nearly 30 pounds since starting on Mounjaro, a GLP-1 medication. Dr. Sanjay Gupta reports.

GLP-1 agonists like Ozempic effectively help manage obesity, but quitting the medication can lead to a resurgence in weight and related health issues. Gradual cessation is advised to avoid sudden ...

Between Novo Nordisk's (NVO) slightly disappointing results for its latest GLP-1 candidate, CagriSema, and questions that remain about Amgen's (AMGN) highly anticipated once-monthly injectable ...

"It was the strangest feeling, because I never felt better about my physical appearance, but I also didn't want my husband to ...

The weight-loss properties of GLP-1 drugs, including Ozempic and Wegovy, have dominated headlines. But could they also cut alcohol consumption? And what would this mean for beverage manufacturers? The ...